Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

8 823 evidences · page 48 / 353

770 000 deathsHIV resulted in 770,000 deaths annually globally in 2018.

NigeriaVIH/sidaobservé 2018publié 2021Journal of medical virologyPubMeddocument de 11 observations

2,6 %The prevalence of Gestational Diabetes Mellitus (GDM) in the study was 2.6% using the 1999 WHO diagnostic criteria.

Nigeriagestational diabetes mellitus (GDM)publié 2020The Pan African medical journalPubMeddocument de 5 observations

49,5 %HSV-2 prevalence among sexual and gender minorities with HIV-1 in Lagos, Nigeria was 49.5%.

NigeriaHerpes simplex virus type 2 · VIH/sidapublié 2023AIDS research and human retrovirusesPubMeddocument de 3 observations

35,8 %The prevalence of optimal short-term glycemic control among Type 2 diabetic patients was 35.8%.

Nigeriadiabète de type 2publié 2025African health sciencesPubMeddocument de 5 observations

65,8 %Of the 73 participants with diabetes mellitus, 65.8% were males.

Nigeriadiabète (non précisé)observé March-May 2021publié 2022International journal of environmental research and public healthPubMeddocument de 12 observations

76 %The prevalence of neurologic conditions among stable COPD patients in a Nigerian hospital's chest clinic was 76.0%.

NigeriaCOPD · neurologic conditionspublié 2025West African journal of medicinePubMeddocument de 20 observations

11,1 %The prevalence of anaemia was 11.1% among patients infected with malaria alone.

Nigeriaanémie · paludismepublié 2013African health scienceseurope_pmcdocument de 5 observations

1 MOIThe multiplicity of infection (MOI) per household ranged from 1.0 to 4.5.

Nigeriapaludismepublié 2020Malaria journalPubMeddocument de 7 observations

76,7 %76.7% of respondents were Christians in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobservé 2018publié 2019Journal of global oncologyPubMeddocument de 9 observations

38,7 %Low grade squamous intraepithelial lesion (LGSIL) had the highest frequency at 38.7% among pre-malignant lesions.

Nigerialow grade squamous intraepithelial lesion (LGSIL)observé 2017publié 2022The Pan African medical journalPubMeddocument de 7 observations

48 %The seroprevalence of chikungunya and malaria was 48.0% in the southern region of Nigeria.

Nigeriachikungunyapublié 2022International journal of environmental research and public healthPubMeddocument de 6 observations

3 979 casesThe incidence patterns model predicted 3979 new HIV infections among the 15 to 49 subpopulations in Lagos state.

NigeriaVIH/sidapublié 2024Journal of the International Association of Providers of AIDS CarePubMeddocument de 7 observations

Malaria incidence was higher in the months with the highest rainfall recorded (June–August) in Abuja, Nigeria, between 2000 and 2013.

Nigeriapaludismeobservé 2000 to 2013publié 2020International journal of environmental research and public healthPubMeddocument de 5 observations

25 %In 2022, test positivity rate (TPR) at Secondary Health Facilities (SHFs) decreased from 25% to 18%.

Nigeriapaludismeobservé 2022publié 2025Malaria journalPubMeddocument de 9 observations

19,2 weeksMean time to death during treatment among DR-TB patients is 19.2 weeks.

NigeriaDrug-Resistant tuberculosis (DR-TB)publié 2019PloS onePubMeddocument de 10 observations

0,035 p-valueAssociation analysis between paired single alleles at pfcrt and pfmdr1 loci showed a significant association (p=0.0349).

Nigeriapaludismepublié 2006Parasitology researcheurope_pmcdocument de 12 observations

11 %Only 11% of the treatment cards had patient adherence to isoniazid assessed.

NigeriaVIH/sidapublié 2022Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument de 4 observations

23,7 %Malaria prevalence was 23.7% among women who had a 2-month interval between each sulfadoxine-pyrimethamine dose.

Nigeriapaludismepublié 2022African health sciencesPubMeddocument de 22 observations

41 804 casesNigeria had 41,804 confirmed SARS-CoV-2 cases as of 29 July 2020.

NigeriaCOVID-19observé 29 July 2020HAL · Unilimdocument de 97 observations

25 %Breast cancer constitutes 25% of all cancer cases diagnosed in Kano State, Nigeria.

Nigeriacancer du seinpublié 2025Breast cancer (Tokyo, Japan)PubMeddocument de 8 observations

44 %Breast cancer has a 5-year survival of 44% in Nigeria.

Nigeriacancer du seinpublié 2026JCO global oncologyPubMeddocument de 3 observations

0 p-valueA positive correlation was observed between RDW and MCHC (p-value = 0.0002) in patients with type II diabetes mellitus.

Nigeriadiabète (non précisé)publié 2023West African journal of medicinePubMeddocument de 8 observations

0,6 proportionOver 6 in 10 women and girls living with HIV had limited access to HIV services during the COVID-19 pandemic in Nigeria.

NigeriaVIH/sidaobservé 2021publié 2022African journal of AIDS research : AJARPubMeddocument de 4 observations

32,9 %In a study of 146 HIV-infected children in Calabar, Nigeria, conducted from February 1 to September 30, 2015, the prevalence of microalbuminuria was 32.9%.

Nigeriamicroalbuminuria · VIH/sidaobservé February 1 to September 30, 2015publié 2022Saudi journal of kidney diseases and transplantation : an official publication of the SaudPubMeddocument de 5 observations

Of 51 consecutive children with cerebral malaria, fever, convulsions, and drowsiness were the commonest presenting symptoms.

Nigeriapaludismepublié 1997African journal of medicine and medical scienceseurope_pmcdocument de 7 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.